Electromedical Technologies, Inc.

Symbol: EMED

PNK

0.00055

USD

Market price today

  • -0.1760

    P/E Ratio

  • 0.0019

    PEG Ratio

  • 0.28M

    MRK Cap

  • 0.00%

    DIV Yield

Electromedical Technologies, Inc. (EMED) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.78%

Operating Profit Margin

-1.53%

Net Profit Margin

-1.07%

Return on Assets

-1.93%

Return on Equity

0.67%

Return on Capital Employed

0.79%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Devices
CEO:Mr. Matthew N. Wolfson
Full-time employees:8
City:Scottsdale
Address:16561 North 92nd Street
IPO:2021-01-08
CIK:0001715819

Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. It offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. The company was founded in 2002 and is headquartered in Scottsdale, Arizona.

General Outlook

When we look at how much money they make before expenses, they keep 0.775% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -1.531%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -1.073%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -1.934% return, is a testament to Electromedical Technologies, Inc.'s adeptness in optimizing resource deployment. Electromedical Technologies, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.665%. Furthermore, the proficiency of Electromedical Technologies, Inc. in capital utilization is underscored by a remarkable 0.792% return on capital employed.

Liquidity Ratios

Analyzing EMED liquidity ratios reveals its financial health of the firm. The current ratio of 13.38% gauges short-term asset coverage for liabilities. The quick ratio (2.74%) assesses immediate liquidity, while the cash ratio (2.61%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio13.38%
Quick Ratio2.74%
Cash Ratio2.61%

Profitability Ratios

EMED profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -195.82% underscores its earnings before tax deductions. The effective tax rate stands at 30.18%, revealing its tax efficiency. The net income per EBT, 54.81%, and the EBT per EBIT, 127.91%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -153.09%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-195.82%
Effective Tax Rate30.18%
Net Income per EBT54.81%
EBT per EBIT127.91%
EBIT per Revenue-153.09%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.13, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding3
Days of Inventory Outstanding82
Operating Cycle83.64
Days of Payables Outstanding288
Cash Conversion Cycle-205
Receivables Turnover306.62
Payables Turnover1.27
Inventory Turnover4.43
Fixed Asset Turnover4.51
Asset Turnover1.80

Cash Flow Ratios

Lastly, the operating cash flow sales ratio, -1.06, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow Sales Ratio-1.06
Free Cash Flow to Operating Cash Flow Ratio1.10
Cash Flow Coverage Ratio-0.90
Short Term Coverage Ratio-0.99
Capital Expenditure Coverage Ratio-9.54
Dividend Paid and Capex Coverage Ratio-9.54

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 212.77%, highlights its total liabilities relative to assets. With a debt-equity ratio of -0.55, we discern the balance between debt and equity financing. The long-term debt to capitalization, -5.51%, and total debt to capitalization, -124.36%, ratios shed light on its capital structure. An interest coverage of -2.31 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio212.77%
Debt Equity Ratio-0.55
Long Term Debt to Capitalization-5.51%
Total Debt to Capitalization-124.36%
Interest Coverage-2.31
Cash Flow to Debt Ratio-0.90
Company Equity Multiplier-0.26

Per Share Data

Net income per share, -0.01, reflects the portion of profit attributed to each share. The book value per share, -0.01, represents the net asset value distributed per share, while the tangible book value per share, -0.01, excludes intangible assets.

cards.indicatorcards.value
Net Income Per Share-0.01
Book Value Per Share-0.01
Tangible Book Value Per Share-0.01
Shareholders Equity Per Share-0.01
Interest Debt Per Share0.01

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 17.30%, indicates top-line expansion, while the gross profit growth, 17.14%, reveals profitability trends. EBIT growth, -28.77%, and operating income growth, -28.77%, offer insights into operational profitability progression. The net income growth, 43.20%, showcases bottom-line expansion, and the EPS growth, 79.89%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth17.30%
Gross Profit Growth17.14%
EBIT Growth-28.77%
Operating Income Growth-28.77%
Net Income Growth43.20%
EPS Growth79.89%
EPS Diluted Growth79.89%
Weighted Average Shares Growth182.36%
Weighted Average Shares Diluted Growth182.36%
Operating Cash Flow Growth-83.28%
Free Cash Flow Growth-102.64%
10-Year Revenue Growth per Share-92.76%
5-Year Revenue Growth per Share-92.76%
3-Year Revenue Growth per Share-89.19%
10-Year Operating CF Growth per Share77.50%
5-Year Operating CF Growth per Share77.50%
3-Year Operating CF Growth per Share93.73%
10-Year Net Income Growth per Share93.38%
5-Year Net Income Growth per Share93.38%
3-Year Net Income Growth per Share96.63%
10-Year Shareholders Equity Growth per Share94.14%
5-Year Shareholders Equity Growth per Share94.14%
3-Year Shareholders Equity Growth per Share87.12%
Receivables Growth-53.42%
Inventory Growth10.40%
Asset Growth-44.70%
Book Value per Share Growth54.19%
Debt Growth-14.06%
R&D Expense Growth150.74%
SGA Expenses Growth33.37%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,874,893.423, captures the company's total value, considering both debt and equity. Income quality, 0.54, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 1.67, gauges operational efficiency, while the research and development to revenue, 17.16%, highlights investment in innovation.

cards.indicatorcards.value
Enterprise Value1,874,893.423
Income Quality0.54
Sales General and Administrative to Revenue1.67
Research and Development to Revenue17.16%
Capex to Operating Cash Flow10.56%
Capex to Revenue-11.10%
Capex to Depreciation-571.28%
Stock-Based Compensation to Revenue53.01%
Graham Number0.03
Return on Tangible Assets-352.93%
Graham Net Net-0.01
Working Capital-2,907,369
Tangible Asset Value-2,872,787
Net Current Asset Value-3,171,985
Invested Capital-1
Average Receivables6,921.5
Average Payables253,112.5
Average Inventory65,289
Days Sales Outstanding1
Days Payables Outstanding284
Days of Inventory On Hand81
ROIC161.27%
ROE0.92%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -0.09, and the price to book ratio, -0.09, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.21, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.18, and price to operating cash flows, -0.18, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio-0.09
Price to Book Ratio-0.09
Price to Sales Ratio0.21
Price Cash Flow Ratio-0.18
Enterprise Value Multiple0.55
Price Fair Value-0.09
Price to Operating Cash Flow Ratio-0.18
Price to Free Cash Flows Ratio-0.18
Price to Tangible Book Ratio-0.09
Enterprise Value to Sales1.39
Enterprise Value Over EBITDA-0.92
EV to Operating Cash Flow-1.32
Earnings Yield-1000.28%
Free Cash Flow Yield-593.48%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Electromedical Technologies, Inc. (EMED) on the PNK in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.176 in 2024.

What is the ticker symbol of Electromedical Technologies, Inc. stock?

The ticker symbol of Electromedical Technologies, Inc. stock is EMED.

What is company IPO date?

IPO date of Electromedical Technologies, Inc. is 2021-01-08.

What is company current share price?

Current share price is 0.001 USD.

What is stock market cap today?

The market cap of stock today is 279008.000.

What is PEG ratio in 2024?

The current 0.002 is 0.002 in 2024.

What is the number of employees in 2024?

In 2024 the company has 8.